MAIA Biotechnology Statistics
Total Valuation
MAIA has a market cap or net worth of $47.93 million. The enterprise value is $38.33 million.
Important Dates
The last earnings date was Friday, March 21, 2025, after market close.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MAIA has 29.59 million shares outstanding. The number of shares has increased by 67.38% in one year.
Current Share Class | 29.59M |
Shares Outstanding | 29.59M |
Shares Change (YoY) | +67.38% |
Shares Change (QoQ) | +4.80% |
Owned by Insiders (%) | 15.69% |
Owned by Institutions (%) | 14.12% |
Float | 24.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 11.66 |
P/TBV Ratio | 13.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65
Current Ratio | 2.65 |
Quick Ratio | 2.53 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -297,494.91 |
Financial Efficiency
Return on equity (ROE) is -1,131.02% and return on invested capital (ROIC) is -515.46%.
Return on Equity (ROE) | -1,131.02% |
Return on Assets (ROA) | -119.60% |
Return on Invested Capital (ROIC) | -515.46% |
Return on Capital Employed (ROCE) | -268.09% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.68% in the last 52 weeks. The beta is 0.21, so MAIA's price volatility has been lower than the market average.
Beta (5Y) | 0.21 |
52-Week Price Change | -34.68% |
50-Day Moving Average | 1.80 |
200-Day Moving Average | 2.54 |
Relative Strength Index (RSI) | 43.32 |
Average Volume (20 Days) | 126,043 |
Short Selling Information
The latest short interest is 708,718, so 2.40% of the outstanding shares have been sold short.
Short Interest | 708,718 |
Short Previous Month | 986,712 |
Short % of Shares Out | 2.40% |
Short % of Float | 2.84% |
Short Ratio (days to cover) | 5.25 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.96M |
Pretax Income | -28.08M |
Net Income | -23.25M |
EBITDA | n/a |
EBIT | -16.96M |
Earnings Per Share (EPS) | -$1.05 |
Full Income Statement Balance Sheet
The company has $9.60 million in cash and n/a in debt, giving a net cash position of $9.60 million or $0.32 per share.
Cash & Cash Equivalents | 9.60M |
Total Debt | n/a |
Net Cash | 9.60M |
Net Cash Per Share | $0.32 |
Equity (Book Value) | 3.63M |
Book Value Per Share | 0.14 |
Working Capital | 6.32M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -15.70M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |